We could not assess the association of EGFr 10–11 PV with age at first stroke or survival because the number of patients with a PV in the ligand-binding domain in the Dutch CADASIL sample was too low for reliable analysis. This evidence concerns the gene EGFR and acquired polycythemia vera.